| Ytd | 275.46% | |
| 1y | 365.91% |
| Open | 10.11 | Prev Close | 10.02 | Low | 9.83 | High | 10.27 | Mkt Cap | 4.64B |
| Vol | 22.88M | Avg Vol | 16.60M | EPS | -0.69 | P/E | N/A | Forward P/E | -37.76 |
| Beta | 0.83 | Short Ratio | 4.57 | Inst. Own | 70.68% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 6.67 | 200-d Avg | 4.20 | 1yr Est | 10.22 |
Iovance Biotherapeutics (NASDAQ: IOVA) said it is expanding its tumor-infiltrating lymphocyte, or TI
Iovance Biotherapeutics NASDAQ: IOVA said it is expanding its tumor-infiltrating lymphocyte, or TIL,
SAN CARLOS, Calif., Sept. 18, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA)
Biotech M&A surges in 2026, putting ABVX, IOVA, VKTX and BCRX on watchlists, as drugmakers seek late
Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight a
Squarepoint Ops LLC lessened its stake in Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) by 68.5% in t
Iovance Biotherapeutics (NASDAQ: IOVA - Get Free Report) and eXoZymes (NASDAQ: EXOZ - Get Free Repor
VIRGINIA RETIREMENT SYSTEMS ET Al purchased a new position in shares of Iovance Biotherapeutics, Inc
Shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA - Get Free Report) reached a new 52-week high
Jupiter Topco LLC acquired a new stake in shares of Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) dur
SAN CARLOS, Calif., Sept. 04, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA),
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
Oncology innovation is driving new treatment options, with Iovance, Merit Medical and Kura advancing
Halozyme, Repligen, Iovance, Arcutis and Precigen have been highlighted in this Industry Outlook art
New drug approvals and encouraging pipeline progress should maintain momentum in the Zacks Biomedica
TD Cowen analyst Nicholas Lorusso maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Buy and
SAN CARLOS, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) (
Shares of Iovance Biotherapeutics Inc. (NASDAQ:IOVA) are trending Friday morning, continuing a momen
Shares of Iovance Biotherapeutics are trending Friday morning after a momentum surge pushed the biot
Iovance Biotherapeutics Inc. (NASDAQ:IOVA) is trading at a 52-week high on Thursday, despite having
Iovance Biotherapeutics stock hits a 52-week high as investors weigh Moderna-Merck cancer data, Amta
Does Iovance Biotherapeutics (IOVA) have what it takes to be a top stock pick for momentum investors
UBS analyst David Dai maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Neutral and raises t
Dow Jones down 300 points, Deere & Co shares up 7.9% after beating earnings expectations. SCTX,
Iovance Biotherapeutics, Inc. delivered a breakout Q2 '26 for Amtagvi sales, with management guiding
Dow Jones up 200 points on Wed. Estee Lauder & other top stocks record gains after reporting str
Mizuho analyst Mara Goldstein maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Outperform a
Iovance's revenue rose 66% last quarter due to strong demand for Amtagvi. The company also cut its l
Barclays analyst Etzer Darout maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Overweight a
Citizens analyst Reni J. Benjamin maintains Iovance Biotherapeutics (NASDAQ:IOVA) with a Market O
Iovance rises 43% after Q2 results top estimates as Amtagvi sales beat forecasts, boosting revenues
Iovance Biotherapeutics Inc (NASDAQ:IOVA) shares are surging Thursday after the cancer therapy compa
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 107.8% to $1.39 during Thursday'
US stocks mixed on Thurs. Dow Jones down 50 pts. Motorola Solutions Inc shares up 9.5% after reporti
Gainers Creative Medical Tech (NASDAQ:CELZ) stock increased by 86.9% to $1.25 during Thursday's
Iovance Biotherapeutics (NASDAQ:IOVA) affirms FY2026 sales outlook from $350.000 million-$370.000 mi
This whale alert can help traders discover the next big trading opportunities. Whales are entities w
https://www.sec.gov/Archives/edgar/data/1425205/000110465926075778/iova-20260618xs3asr.htm
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma
U.S. stock futures fall 250 points, Highpeak Energy shares drop 7%. Other stocks also down in pre-ma
Top Wall Street analysts changed outlook on top names. Check out all changes, including upgrades, do